Bench to bedside and beyond: evolving trends in translational research

Article Sidebar

PDF
Published: 2025-10-12
DOI: https://doi.org/10.18051/UnivMed.2025.v44.285-287

Main Article Content

Juhi Aggarwal
Department of Biochemistry, Santosh Medical College & Hospital, Santosh Deemed To Be University, Ghaziabad, Uttar Pradesh- 20100
https://orcid.org/0000-0003-2883-6785

Article Details

Issue

Vol. 44 No. 3 (2025): Ahead Of Print

Section

Editorial
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

The journal allows the authors to hold the copyright without restrictions and allow the authors to retain publishing rights without restrictions.

How to Cite

Bench to bedside and beyond: evolving trends in translational research. (2025). Universa Medicina, 44(3), 285-287. https://doi.org/10.18051/UnivMed.2025.v44.285-287

References

1. Subramanian M, Wojtusciszyn A, Favre L, et al. Precision medicine in the era of artificial intelligence: implications in chronic disease management. J Transl Med 2020;18:472. doi: 10.1186/s12967-020-02658-5.18, 472.

2. Mensah GA, Czajkowski SM. Translational science matters: forging partnerships between biomedical and behavioral science to advance the public's health. Transl Behav Med 2018;8:808-14. doi: 10.1093/tbm/ibx023.

3. Gutierrez-Vargas JA. Translational medicine: bridging the gap between bench and bedside. J Experi Stroke Trans Med 2023;15:105-6. doi: 10.37532/jestm.2023.15(5).105-106.

4. June CH, Sadelain M. Chimeric antigen receptor therapy. N Engl J Med 2018;379:64–73. doi: 10.1056/NEJMra1706169.

5. Mendes LMC, Lino LA, Bordignon TM, et al. Edição de genes CRISPR-Cas9 e suas aplicações terapêuticas: Uma revisão de literatura. [CRISPR-Cas9 gene editing and its therapeutic applications: a literature review]. Res Soc Dev 2024;13:e11513846681. Portuguese. doi: 10.33448/rsd-v13i8.46681.

6. Isik S, Osman S, Yeman-Kiyak B, Shamshir SRM, Sanchez NME. Advances in neurodegenerative disease therapy: stem cell clinical trials and promise of engineered exosomes. CNS Neurosci Ther 2025;31:e70577. doi: 10.1111/cns.70577.

7. Collins FS, Varmus H. A new initiative on precision medicine. N Engl J Med 2015;372:793–5. doi: 10.1056/NEJMp1500523.

8. Han F, Wang J, Ding L, et al. Tissue engineering and regenerative medicine: achievements, future, and sustainability in Asia. Front Bioeng Biotechnol 2020;8:83. doi: 10.3389/fbioe.2020.00083.

9. Seyhan AA. Lost in translation: the valley of death across preclinical and clinical divide – identification of problems and overcoming obstacles. Transl Med Commun 2019;4:18. doi: 10.1186/s41231-019-0050-7.

10. Topol EJ. High-performance medicine: the convergence of human and artificial intelligence. Nat Med 2019;25:44–56. doi: 10.1038/s41591-018-0300-7.

11. Niemiec E, Howard H. Ethical issues related to research on genome editing in human embryos. Comput Struct Biotechnol J 2020;18:887-96. doi: 10.1016/j.csbj.2020.03.014.

12. Ragon B, Seymour A, Whipple EC, et al. The role of information science within the clinical translational science ecosystem. J Clin Transl Sci 2024; 8: e224. doi: 10.1017/cts.2024.664.

13. Barbosa S, Pare Toe L, Thizy D, Vaz M, Carter L. Engagement and social acceptance in genome editing for human benefit: reflections on research and practice in a global context. Wellcome Open Res 2021;5:244. doi: 10.12688/wellcomeopenres.16260.2.